News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers – FDA Oncology
FDA/YouTube
May 29, 2025, 18:26

Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers – FDA Oncology

FDA Oncology shared a post on X:

“FDA Bench To Bedside video alert! The FDA Oncology Center of Excellence dives into drug development for rare and economically infeasible cancers – with expert voices from across the agency.”

More posts featuring FDA Oncology.

bench-to-bedside cancer drug development FDA Oncology FDA Oncology Center of Excellence OncoDaily Oncology Rare Cancers
Special Coverage
Blog
May 29, 2025, 18:26
Bench To Bedside on Drug Development for Rare and Economically Infeasible Cancers - FDA Oncology
Career
May 29, 2025, 18:16
The First 2025 Mentor of the Year Nominee: Mariana Chavez Mac Gregor - WinC - AlinC
Blog
May 29, 2025, 18:11
Manmeet Ahluwalia: Honored to Receive the Ellis Island Medal of Honor for Contributions to American Society
Positive
May 29, 2025, 17:58
Stephen Liu: Congratulations to the Newly Elected IASLC Board Members
Blog
May 29, 2025, 17:45
3D Printing in Radiation Oncology Workshop - ESTRO
Blog
May 29, 2025, 17:41
Amol Akhade: Can Perioperative Immunotherapy Change Outcomes in Resectable Gastric/GEJ Cancer?
Blog
May 29, 2025, 17:39
Patrick Ma: Looking Forward to ASCO 2025
Blog
May 29, 2025, 17:28
Sarbajit Mukherjee: Academic GI Oncology Opportunity - Let’s Meet at ASCO 2025
Science
May 29, 2025, 17:28
Praveen Kumar Marimuthu: RWD Shows NACT Plus Immunotherapy Nearly Doubles pCR in MIBC
Blog
May 29, 2025, 17:20
Douglas Flora: Unlocking AI for Clinicians and Healthcare Leaders - Let's Boost Our AI Literacy
Science
May 29, 2025, 17:09
Stephen Liu: Molecular Determinants of Efficacy with Sotorasib in KRASG12C NSCLC by Ferdinandos Skoulidis et al.
Career
May 29, 2025, 16:54
Paulo Bergerot: Proud and Grateful for 2024 Reviewer Recognition from JCO Global Oncology